Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Many elite controllers at HIV's ground zero

March 15, 2021

CROI 2021: Sending HIV into the gene desert could be path to functional cure

March 11, 2021

Bi-functionalized nanoparticles described by Vall d'Hebron Institut de Recerca and collaborators

March 5, 2021

Oral islatravir studied in new phase III trials as PrEP for HIV

March 5, 2021

New EFdA prodrugs synthesized at GlaxoSmithKline

March 3, 2021

Activation of CARD8 inflammasome triggers pyroptosis of HIV-1-infected cells

Feb. 24, 2021

Clinical study provides proof of principle for HIV vaccine candidate eOD-GT8 60mer

Feb. 5, 2021

California Institute of Technology, Rockefeller University describe anti-HIV vaccine antibodies

Feb. 4, 2021

CD40-targeting vaccine enhances T- and B-cell responses against HIV-1

Feb. 2, 2021

Merck & Co. presents preliminary safety and PK data for islatravir in HIV-1 pre-exposure prophylaxis

Jan. 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...